Clinical Trials List
2021-06-01 - 2023-12-31
Phase II
Suspended3
-
-
Trial Applicant
TAIWAN TIGERMED CONSULTING CO
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- 戴瑞億 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Ming-Che Kuo Division of Neurology
The Actual Total Number of Participants Enrolled
0 Suspended
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
220 participants
